23 research outputs found
Dipeptidyl peptidase IV inhibition upregulates GLUT4 translocation and expression in heart and skeletal muscle of spontaneously hypertensive rats
The purpose of the current study was to test the hypothesis that the dipeptidyl peptidase IV (DPPIV) inhibitor sitagliptin, which exerts anti-hyperglycemic and anti-hypertensive effects, upregulates GLUT4 translocation, protein levels, and/or mRNA expression in heart and skeletal muscle of spontaneously hypertensive rats (SHRs). Ten days of treatment with sitagliptin (40 mg/kg twice daily) decreased plasma DPPIV activity in both young (Y, 5-week-old) and adult (A, 20-week-old) SHRs to similar extents ( similar to 85%). However, DPPIV inhibition only lowered blood pressure in Y-SHRs (119 +/- 3 vs. 136 +/- 4 mmHg). GLUT4 translocation, total protein levels and mRNA expression were decreased in the heart, soleus and gastrocnemius muscle of SHRs compared to age-matched Wistar Kyoto (WKY) normotensive rats. These differences were much more pronounced between A-SHRs and A-WKY rats than between Y-SHRs and Y-WKY rats. in Y-SHRs, sitagliptin normalized GLUT4 expression in the heart, soleus and gastrocnemius. in A-SHRs, sitagliptin increased GLUT4 expression to levels that were even higher than those of A-WKY rats. Sitagliptin enhanced the circulating levels of the DPPIV substrate glucagon-like peptide-1 (GLP-1) in SHRs. in addition, stimulation of the GLP-1 receptor in cardiomyocytes isolated from SHRs increased the protein level of GLUT4 by 154 +/- 13%. Collectively, these results indicate that DPPIV inhibition upregulates GLUT4 in heart and skeletal muscle of SHRs. the underlying mechanism of sitagliptin-induced upregulation of GLUT4 in SHRs may be, at least partially, attributed to GLP-1. (C) 2012 Elsevier B.V. All rights reserved.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento CientÃfico e Tecnológico (CNPq)Fac Med ABC, Dept Morphol & Physiol, São Paulo, BrazilUniversidade Federal de São Paulo, Dept Med, São Paulo, BrazilUniv São Paulo Med Sch, Inst Heart, Lab Genet & Mol Cardiol, BR-05403900 São Paulo, BrazilUniversidade Federal de São Paulo, Dept Med, São Paulo, BrazilFAPESP: 2007/52945-8CNPq: 480775/2007-9Web of Scienc
Amelioration of Cardiac Function and Activation of Anti-Inflammatory Vasoactive Peptides Expression in the Rat Myocardium by Low Level Laser Therapy
Low-level laser therapy (LLLT) has been used as an anti-inflammatory treatment in several disease conditions, even when inflammation is a secondary consequence, such as in myocardial infarction (MI). However, the mechanism by which LLLT is able to protect the remaining myocardium remains unclear. the present study tested the hypothesis that LLLT reduces inflammation after acute MI in female rats and ameliorates cardiac function. the potential participation of the Renin-Angiotensin System (RAS) and Kallikrein-Kinin System (KKS) vasoactive peptides was also evaluated. LLLT treatment effectively reduced MI size, attenuated the systolic dysfunction after MI, and decreased the myocardial mRNA expression of interleukin-1 beta and interleukin-6 in comparison to the non-irradiated rat tissue. in addition, LLLT treatment increased protein and mRNA levels of the Mas receptor, the mRNA expression of kinin B2 receptors and the circulating levels of plasma kallikrein compared to non-treated post-MI rats. On the other hand, the kinin B1 receptor mRNA expression decreased after LLLT. No significant changes were found in the expression of vascular endothelial growth factor (VEGF) in the myocardial remote area between laser-irradiated and non-irradiated post-MI rats. Capillaries density also remained similar between these two experimental groups. the mRNA expression of the inducible nitric oxide synthase (iNOS) was increased three days after MI, however, this effect was blunted by LLLT. Moreover, endothelial NOS mRNA content increased after LLLT. Plasma nitric oxide metabolites (NOx) concentration was increased three days after MI in non-treated rats and increased even further by LLLT treatment. Our data suggest that LLLT diminishes the acute inflammation in the myocardium, reduces infarct size and attenuates left ventricle dysfunction post-MI and increases vasoactive peptides expression and nitric oxide (NO) generation.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento CientÃfico e Tecnológico (CNPq)Univ Nove Julho, UNINOVE, São Paulo, BrazilUniversidade Federal de São Paulo, UNIFESP, São Paulo, BrazilUniv São Paulo, Heart Inst InCor, São Paulo, BrazilUniversidade Federal de São Paulo, UNIFESP, São Paulo, BrazilCNPq: 477458/2009-2CNPq: 309715/2011-3CNPq: 479395/2012-8: 2009/54225-8Web of Scienc
Role of the AT1 receptor/Gi protein pathway and the myosin IIA motor protein in the upregulation of NHE3 activity by angiotensin II in the renal proximal tubule
A isoforma 3 do trocador Na+ /H+ (NHE3), presente em membrana apical, é a proteÃna de transporte que medeia a maior parte da reabsorção de NaCl e NaHCO3- em túbulo proximal renal. A fosforilação direta do NHE3 por PKA na serina 552 é um dos mecanismos pelos quais a sua atividade pode ser inibida. A ligação da angiotensina II (Ang II) ao receptor AT1 (AT1R) em túbulo proximal estimula a atividade do NHE3 por diferentes vias de sinalização. Entretanto, não foram ainda bem estabelecidos os efeitos da ativação da via AT1R/Gi, com consequente diminuição nos nÃveis de cAMP, na regulação do NHE3. A Ang II pode ainda estimular a atividade do NHE3 por promover a sua translocação da base para o corpo das microvilosidades, entretanto, o papel da proteÃna motora miosina IIA nesta translocação em resposta à Ang II ainda não foi estabelecido. Sendo assim esta tese teve como objetivos: (1) testar a hipótese de que a Ang II diminui os nÃveis de fosforilação do NHE3 mediados pelo cAMP/PKA na serina 552 aumentando a sua atividade por reduzir os nÃveis de cAMP e (2) testar a hipótese de que a miosina IIA participa da redistribuição do NHE3 da base para o corpo das microvilosidades em túbulo proximal renal em condições de estÃmulo da reabsorção de sódio, como ocorre em resposta à Ang II. Visando avaliar os efeitos da ativação da via AT1R/Gi na regulação do NHE3, verificamos, por meio da técnica de recuperação do pH dependente de Na+, que, em condições basais, a Ang II estimulou a atividade do NHE3, mas não alterou a atividade da PKA e nem afetou os nÃveis de fosforilação do NHE3 na serina 552 em uma linhagem de células de túbulo proximal (OKP). Entretanto, na presença da forskolin (FSK), agente que eleva os nÃveis intracelulares de cAMP, a Ang II foi capaz de contrapor-se ao efeito inibitório da FSK sobre o NHE3 por promover redução na concentração de cAMP, diminuição da atividade da PKA e, consequentemente, diminuição nos nÃveis de fosforilação da serina 552. Todos os efeitos da Ang II foram bloqueados quando um pré-tratamento com Losartan, antagonista do receptor AT1, foi feito nas células OKP, destacando a contribuição da via AT1R/proteÃna Gi no aumento da atividade do NHE3 pela Ang II. Observamos que a inibição da proteÃna Gi com PTX (toxina pertussis) diminuiu a atividade do NHE3 em células OKP e que a PTX diminuiu a atividade do NHE3 assim como preveniu o efeito estimulatório da Ang II sobre a atividade do NHE3 em túbulo proximal de ratos Wistar. Adicionalmente, com a intenção de avaliar os efeitos da miosina IIA na redistribuição do NHE3, constatamos que a blebistatina, inibidor da miosina IIA, preveniu completamente o aumento de atividade do NHE3 mediado pela Ang II em ratos Wistar e que o uso da blebistatina foi capaz de prevenir o aumento do NHE3 na superfÃcie de células OKP tratadas com Ang II. Em conjunto, nossos resultados sugerem que a Ang II contrapõe-se aos efeitos do cAMP/PKA sobre a fosforilação e a atividade do NHE3 pela ativação da via AT1R/Gi e que a miosina IIA desempenha um papel na mediação da regulação da atividade do NHE3 em túbulo proximal renal de ratos em resposta à Ang II. Sugerem ainda que a desfosforilação do NHE3 na serina 552 pode representar um evento chave na regulação do manuseio de sal tubular proximal pela Ang II na presença de hormônios natriuréticos que promovem o aumento dos nÃveis de cAMP e da fosforilação do transportador e que a miosina IIA está envolvida na regulação do tráfego do NHE3 em túbulo proximal renalThe Na+/H+ exchanger isoform 3 (NHE3), expressed on the apical membrane, is responsible for most NaCl and NaHCO3 - reabsorption in the renal proximal tubule. Direct phosphorylation of NHE3 by PKA at serine 552 is one of the mechanisms by which its activity is inhibited. Binding of angiotensin II (Ang II) to the AT1 receptor (AT1R) in the proximal tubule stimulates NHE3 activity through multiple signaling pathways. However, the effects of AT1R/Gi activation and subsequent decrease in cAMP accumulation on NHE3 regulation are not well established. Ang II can also stimulate NHE3 activity by promoting its translocations from the base to the body of the microvilli, however, the role of the myosin IIA motor protein in this translocation in response to Ang II is not yet established. Therefore, the aims of this thesis are: (1) to test the hypothesis that Ang II decreases the cAMP/PKA-mediated NHE3 phosphorylation levels at serine 552 increasing its activity by reducing cAMP levels and (2) to test the hypothesis that myosin IIA participates in the NHE3 redistribution from the base to the body of the microvilli in the renal proximal tubule under conditions in which sodium reabsorption is stimulated, such as in response to Ang II. In order to evaluate the effects of AT1R/Gi pathway activation on NHE3 regulation, by means the intracellular pH recovery technique, we verified that under basal conditions, Ang II stimulated NHE3 activity but did not affect PKA-mediated NHE3 phosphorylation at serine 552 in opossum kidney (OKP) cells. However, in the presence of the cAMP-elevating agent forskolin (FSK), Ang II counteracted FSK-induced NHE3 inhibition, reduced intracellular cAMP concentrations, lowered PKA activity, and prevented the FSK-mediated increase in NHE3 serine 552 phosphorylation. All effects of Ang II were blocked by pretreating OKP cells with the AT1R antagonist Losartan, highlighting the contribution of the AT1R/Gi pathway in Ang II-mediated NHE3 upregulation under cAMP-elevating conditions. We also verified that Gi protein inhibition by pertussis toxin treatment decreased NHE3 activity both in vitro and in vivo and, more importantly, prevented the stimulatory effect of Ang II on NHE3 activity in Wistar rat proximal tubules. Additionally, we assessed the effects of myosin IIA on NHE3 redistribution, and found that blebbistatin, a myosin IIA inhibitor, completely prevented the increase of Ang II-mediated NHE3 activity in Wistar rats and that blebbistatin was able to prevent the increase of NHE3 on the Ang II-treated OKP cells surface. Collectively, our results suggest that Ang II counteracts the effects of cAMP/PKA on NHE3 phosphorylation and inhibition by activating the AT1R/Gi pathway and that myosin IIA plays a role in mediating the NHE3 activity regulation in the rat renal proximal tubule in response to Ang II. Furthermore, these findings support the notion that NHE3 dephosphorylation at serine 552 may represent a key event in the regulation of renal proximal tubule sodium handling by Ang II in the presence of natriuretic hormones that promote cAMP accumulation and transporter phosphorylation, and that myosin IIA is involved in NHE3 trafficking regulation in the renal proximal tubul
Differential regulation of Na+/H+ exchanger NHE3 in renal proximal tubule before and after development of hypertension
A hipertensão arterial essencial é caracterizada pela elevação crônica da pressão arterial e representa o principal fator de risco para doenças cardiovasculares e renais. O rim participa do controle da pressão arterial e alterações intrÃnsecas no manuseio renal de sódio desempenham papel importante na patogênese da hipertensão essencial. Os túbulos proximais renais são responsáveis pela reabsorção da maior parte do sódio filtrado nos glomérulos e a maior parte da reabsorção de sódio neste segmento faz-se através da troca de Na+ por H+ em membrana apical, mediada pela isoforma 3 do trocador Na+/H+ (NHE3). Entretanto, os dados existentes referentes à modulação renal do NHE3 em modelos de hipertensão são ainda conflitantes. Este estudo teve como objetivo avaliar as possÃveis alterações funcionais do trocador Na+/H+ NHE3 em túbulo proximal renal na linhagem SHR no estágio de préhipertensão (5 semanas) e de hipertensão (14 semanas) e investigar se estas alterações são acompanhadas de alterações na atividade e na expressão da proteÃna cinase A (PKA) e de proteÃnas fosfatase-1 (PP1). Por meio de microperfusão estacionária in vivo mediu-se a atividade do NHE3 em túbulo proximal e verificou-se que a reabsorção de bicarbonato foi reduzida em 62 ± 6 % (P < 0,001) na transição do J-SHR para o A-SHR enquanto foi aumentada em 113 ± 10 % (P < 0,001) na transição entre o J-WKY e o A-WKY. A atividade estimulada do NHE3 em J-SHR é decorrente da redistribuição do NHE3 do domÃnio intermicrovilar (IMV) para o domÃnio das microvilosidades (MMV) e do baixo nÃvel de fosforilação da serina 552, sÃtio consenso para a PKA. Por outro lado, durante a fase de hipertensão, a atividade diminuÃda do NHE3 deve-se à sua redistribuição para o IMV e ao aumento da fosforilação na serina 552. Para testar a hipótese de que os nÃveis de fosforilação do NHE3 estariam aumentados em túbulo proximal de SHR adulto devido ao aumento da atividade da PKA e/ou à diminuição na atividade da PP1, foram avaliados tanto os nÃveis de fosforilação quanto a atividade do NHE3 em SHR jovens e adultos em resposta ao 6MB-cAMP (análogo ao cAMP que ativa especificamente a PKA). O JSHR apresentou um aumento tanto nos nÃveis de fosforilação da serina 552 (179 ± 14 %, P < 0,001) quanto nos de inibição da atividade (65 ± 10 %, P < 0,001) do NHE3 em relação ao J-SHR em resposta ao 6MB-cAMP. Já no A-SHR, a fosforilação da serina 552 aumentou moderadamente (36 ± 4 %, P < 0,01), assim como inibiu moderadamente (23 ± 9 %, P < 0,05) a atividade do NHE3 em resposta ao 6MBcAMP. Adicionalmente, verificou-se que não houve alteração da atividade da PKA entre os animais nem ao longo da idade e nem entre as linhagens. Por sua vez, o JSHR apresentou maior atividade da PP1 que o A-SHR (1640 ± 107 vs. 940 ± 119 pM/?g, P < 0,01). Além disso, houve uma diminuição na expressão da PP1? no ASHR (32 ± 8 %, P < 0,01) quando comparado ao J-SHR. Os dados sugerem que o NHE3 é diferencialmente regulado antes e após o desenvolvimento da hipertensão em SHR por mecanismos que envolvem modificações pós-transcricionais e distribuição subcelular. Além do mais, a regulação diferencial dos nÃveis de fosforilação do NHE3 tubular proximal antes e após o desenvolvimento da hipertensão em SHR é devida, provavelmente, a alterações na atividade e na expressão da PP1Essential hypertension is characterized by chronic elevation of blood pressure and represents the major risk factor for cardiovascular and renal diseases. The kidney participates in the blood pressure control and intrinsic changes in renal sodium handling play an important role in the pathogenesis of essential hypertension. The renal proximal tubule is responsible for reabsorption of the great majority of sodium that is filtered by the glomerulus and the principal apical membrane mechanism for sodium reabsorption in this nephron is Na+/H+ exchanger isoform 3 (NHE3)- mediated Na+/H+ exchange. However, conflicting data have been reported with regard to NHE3 modulation in experimental models of hypertension. This study aimed to evaluate the possible functional changes of the Na+/H+ exchanger NHE3 in the renal proximal tubule of SHR both at the pre-hypertensive (5 weeks) and at hypertensive (14 weeks) stages and to investigate whether these changes were accompanied by changes in the activity and/or expression of protein kinase A (PKA) and protein phosphatase 1 (PP1). Proximal tubule NHE3 activity was measured by means of stationary microperfusion. Bicarbonate reabsorption was found to be decreased by 62 ± 6 % (P < 0.001) in the transition from youth to adulthood in SHR (Y-SHR to A-SHR), whereas in the transition from Y-WKY to A-WKY it increased by 113 ± 10 % (P < 0.001). Stimulated NHE3 activity in Y-SHR was due to redistribution of NHE3 from intermicrovilar domain (IMV) to microvilar domain (MMV) and to a lower level of serine 552 phosphorylation, a consensus site for PKA. Conversely, during the hypertensive stage, decreased NHE3 activity was due to increased redistribution of NHE3 to the IMV domain and increased phosphorylation at serine 552. To test the hypothesis that the increased levels of NHE3 phosphorylation in the proximal tubule of adult SHR were due to increased PKA activity and/or decreased PP1 activity, it was evaluated both phosphorylation levels and activity of NHE3 in young and adult SHR in response to 6MB-cAMP (an cAMP analog that specifically activates PKA). Y-SHR showed an increase both in the phosphorylation levels at serine 552 (179 ± 14 %, P < 0.001) and in the inhibition of NHE3 transport activity (65 ± 10 %, P < 0.001) compared to Y-SHR in response to 6MB-cAMP. With respect to A-SHR, the phosphorylation of serine 552 was slightly increased (36 ± 4 %, P < 0.01) and NHE3 activity was mildly inhibited (23 ± 9 %, P < 0.05) in response to 6MB-cAMP. Additionally, PKA activity remained unchanged with both age and strain. Nevertheless, Y-SHR exhibited higher PP1 activity than A-SHR (1640 ± 107 vs. 940 ± 119 pM/?g, P < 0.01). Furthermore, PP1? expression was decreased in the renal cortex of A-SHR (32 ± 8 %, P < 0.01) compared to Y-SHR. Taken together, these data suggest that NHE3 is differentially regulated before and after development of hypertension in SHR by mechanisms involving post-translational modifications and subcellular distribution. Moreover, the differential regulation of proximal tubule NHE3 phosphorylation levels before and after development of hypertension in SHR is most likely due to changes on the activity and expression of PP
Renal Effects and Underlying Molecular Mechanisms of Long-Term Salt Content Diets in Spontaneously Hypertensive Rats.
Several evidences have shown that salt excess is an important determinant of cardiovascular and renal derangement in hypertension. The present study aimed to investigate the renal effects of chronic high or low salt intake in the context of hypertension and to elucidate the molecular mechanisms underlying such effects. To this end, newly weaned male SHR were fed with diets only differing in NaCl content: normal salt (NS: 0.3%), low salt (LS: 0.03%), and high salt diet (HS: 3%) until 7 months of age. Analysis of renal function, morphology, and evaluation of the expression of the main molecular components involved in the renal handling of albumin, including podocyte slit-diaphragm proteins and proximal tubule endocytic receptors were performed. The relationship between diets and the balance of the renal angiotensin-converting enzyme (ACE) and ACE2 enzymes was also examined. HS produced glomerular hypertrophy and decreased ACE2 and nephrin expressions, loss of morphological integrity of the podocyte processes, and increased proteinuria, characterized by loss of albumin and high molecular weight proteins. Conversely, severe hypertension was attenuated and renal dysfunction was prevented by LS since proteinuria was much lower than in the NS SHRs. This was associated with a decrease in kidney ACE/ACE2 protein and activity ratio and increased cubilin renal expression. Taken together, these results suggest that LS attenuates hypertension progression in SHRs and preserves renal function. The mechanisms partially explaining these findings include modulation of the intrarenal ACE/ACE2 balance and the increased cubilin expression. Importantly, HS worsens hypertensive kidney injury and decreases the expression nephrin, a key component of the slit diaphragm
Analysis of megalin and cubilin renal protein expression.
<p>(A) Megalin. (B) Cubilin. Data are means ± SEM. (NS) normal salt diet. LS: low salt diet. HS: high salt diet. *P<0.05 vs. NS; + P < 0.05 vs. HS. (n = 6 / group).</p
Parameters of renal function.
<p>Values are represented as the mean± SEM. NS: normal salt diet. LS: low salt diet. HS: high salt diet. GFR: glomerular filtration rate</p><p>*P<0.05 vs. NS</p><p>+ P < 0.05 vs. HS</p><p># P < 0.05 vs LS.</p><p>Parameters of renal function.</p
Analysis of nephrin and podocin renal protein expression.
<p>(A) Nephrin. (B) Podocin. Data are means ± SEM. NS: normal salt diet. LS: low salt diet. HS: high salt diet. *P<0.05 vs. NS; # P < 0.05 vs LS. (N = 6 / group).</p
Renal enzymatic activity of ACE, ACE2 and the ACE/ACE2 ratio.
<p>(A) ACE enzymatic activity. (B) ACE2 enzymatic activity. (C) ACE/ACE2 ratio. Data are means ± SEM. NS: normal salt diet. LS: low salt diet. HS: high salt diet. *P<0.05 vs. NS; + P < 0.05 vs. HS. (NS n = 12, LS n = 10, HS n = 9).</p
Analysis of ACE, ACE2 expression and ACE/ACE2 protein ratio.
<p>(A) ACE kidney expression. (B) ACE2 kidney expression. C: ACE/ACE2 protein ratio. Data are means ± SEM. NS: normal salt diet. LS: low salt diet. HS: high salt diet. *P<0.05 vs. NS; + P < 0.05 vs. HS; # P < 0.05 vs LS.</p